Prevail是一家生物技术公司,致力于为神经退行性疾病患者开发潜在的基于疾病改良AAV9的基因疗法。#生物医药下一个十年# #AAV基因治疗#查看全文
消灵通2020-12-15 22:44
$Prevail Therapeutics(PRVL)$ $礼来(LLY)$ 礼来上涨2%,Prevail Therapeutics飙涨83%;礼来宣布以8.8亿美元或每股22.5美元的价格收购Prevail Therapeutics。查看全文
牛唐2020-12-15 21:55
$礼来(LLY)$ Buy $Prevail Therapeutics(PRVL)$ for $22.50/Share in Cash ,一天一个并购,$美国生科ETF-SPDR(XBI)$ 又要嗨了查看全文
华尔街操盘手_2019-06-21 00:15
$Slack Technologies(WORK)$ $Grocery Outlet(GO)$ $Prevail Therapeutics(PRVL)$ 最全ipo上市列表 网页链接查看全文
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-053723 Act: 34 Size: 315 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-20-290936 Act: 34 Size: 29 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-20-283331 Act: 34 Size: 27 KB 网页链接
$Prevail Therapeutics(PRVL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-113414 Act: 34 Size: 126 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-050091 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-050090 Size: 6 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-20-243118 Act: 34 Size: 34 KB 网页链接
$Prevail Therapeutics(PRVL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-215724 Act: 33 Size: 398 KB 网页链接
$Prevail Therapeutics(PRVL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-039115 Act: 34 Size: 8 MB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001564590-20-039112 Act: 34 Size: 7 MB 网页链接